Investing in NeurANO
NeurANO has received $4 million in non-diluted NIH grants funding, with patents granted in Europe & Japan and pending in the US & China. We have identified a scalable manufacturing process with GMP pathway established.
Now, we're ready to bring our technology to the next level. We are seeking Scientific Advisory Board members and funding partners to get us there.
Help Us Heal Billions
Faulty NMDAR signaling underlies a broad spectrum of neurological and psychiatric disorders. 100M+ patients are actively seeking better treatments, and we expect the market to grow substantially as populations age in the coming decade.
$83B+ global market
First-mover advantage
No competitors can selectively target extrasynaptic NMDARs.
Our platform enables cross-indication leverage, streamlining cost and accelerating timelines, with parallel preclinical programs advancing toward FDA fast-track designation.
Join us.
Please reach out if you are interested in joining our Advisory Board, investing in NeurANO, or pursuing a career as a research scientist or go-to-market leader.
Address
9500 Gilman Blvd MS#0423
La Jolla CA 92093
Contact
business@neuranobio.com
Copyright © 2025
All rights reserved